Subtitle
How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
Subtitle
How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
Proto therapy Time
February 2016
Executive summary
Published in the Green Journal, this ESTRO-HERO (Health Economics in Radiation Oncology) analysis reported about 4 millions new cancer patients are predicted in 2025 in Europe, a 15.9% increase compared to the number of 2012, and about 2 millions cancer patients would have an indication for radiotherapy in 2025, a 16.1% increase from year 2012.
New radiotherapy techniques enable delivery precision and less toxic effects combined with new chemotherapy could also influence the number of candidates for radiotherapy treatments. This paper is to raise awareness for resource planning and placing investments to adequately manage demands of cancer patients.
Key content topics
Related contents
Proton Therapy Publication
June 2023
Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy.
Proton Therapy Publication
April 2023
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
Proton Therapy Publication
March 2023
Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
Proton Therapy Publication
January 2023
Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy.
Webinar
April 22, 2022
The State of Proton Therapy in the U.S.
James
Metz
Proton Therapy Publication
July 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 1/2 Trial.
Proton Therapy Publication
April 2022
A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.
Proton Therapy Publication
February 2022
Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
Proton Therapy Publication
November 2021
Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer.